Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 55-74
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.55
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.55
Table 7 Association with Helicobacter pylori infection and colorectal adenoma/ cancer
Prevalence of H. pylori | Diagnostic tool of H. pylori | Study design | P value | |
Hu et al[113] | OR: 1.44; 95%CI: 1.2-1.73 | Rapid urease test | Retrospective | P < 0.001 |
Sonnenberg et al[122] | OR: 1.52; 95%CI: 1.46-1.57 | Histology | Retrospective | NA |
Liou et al[124] | Case 14.2% vs controls 11.8% | 13C-UBT | Case-control study | P = 0.513 |
Choi et al[126] | OR: 1.49; 95%CI: 1.37-1.62 | Serology, histology, rapid urease test and 13C-UBT | Meta-analysis | P < 0.001 |
Zuo et al[127]1 | OR: 1.70; 95%CI: 1.64-1.76 | Serology, histology and rapid urease test | Meta-analysis | NA |
Colorectal adenoma incidence decreased after H. pylori eradication | ||||
Hu et al[133]2 | HR: 3.04; 95%CI: 1.754-5.280 | Rapid urease test | Retrospective cohort | P < 0.001 |
- Citation: Kuo YC, Yu LY, Wang HY, Chen MJ, Wu MS, Liu CJ, Lin YC, Shih SC, Hu KC. Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum. World J Gastrointest Oncol 2022; 14(1): 55-74
- URL: https://www.wjgnet.com/1948-5204/full/v14/i1/55.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i1.55